Intramembrane proteases of diverse signaling pathways use membrane-embedded active sites to cleave membrane-associated substrates. Interactions of intramembrane metalloproteases with modulators are poorly understood. Inhibition of Bacillus subtilis intramembrane metalloprotease SpoIVFB requires BofA and SpoIVFA, which transiently prevent cleavage of Pro-σK during endosporulation. Three conserved BofA residues (N48, N61, T64) in or near predicted transmembrane segment (TMS) 2 were found to be required for SpoIVFB inhibition. Disulfide cross-linking indicated that BofA TMS2 occupies the SpoIVFB active site region. BofA and SpoIVFA neither prevented SpoIVFB from interacting with Pro-σK in co-purification assays nor interfered with cross-linking between the C-terminal regions of Pro-σK and SpoIVFB. However, BofA and SpoIVFA did interfere with cross-linking between the N-terminal Proregion of Pro-σK and the SpoIVFB active site region and interdomain linker. A BofA variant lacking predicted TMS1, in combination with SpoIVFA, was less effective at interfering with some of the cross-links and slightly less effective at inhibiting cleavage of Pro-σK by SpoIVFB. A structural model was built of SpoIVFB in complex with BofA and parts of SpoIVFA and Pro-σK, using partial homology and constraints from cross-linking and co-evolutionary analyses. The model predicts that N48 in BofA TMS2 interacts with T64 (and possibly N61) of BofA to stabilize a membrane-embedded C-terminal region. SpoIVFA is predicted to bridge the BofA C-terminal region and SpoIVFB. Thus, the two inhibitory proteins block access of the Pro-σK N-terminal region to the SpoIVFB active site region. Our findings may inform efforts to develop selective inhibitors of intramembrane metalloproteases.SignificanceIntramembrane metalloproteases (IMMPs) function in numerous signaling processes that impact health. For example, IMMPs function in pathways regulating human cholesterol levels and bacterial pathogenesis. Knowledge of IMMP interactions with modulators could inform design of therapeutics, but structures of complexes have not been reported. We found that a transmembrane segment of BofA occupies the active site region to inhibit SpoIVFB, an IMMP crucial for endosporulation of Bacillus subtilis. Because endosporulation enhances persistence of related pathogenic bacteria, our structural model of SpoIVFB in complex with BofA and parts of its other inhibitory protein SpoIVFA and its substrate Pro-σK, may lead to strategies to control endosporulation. More broadly, insights from the SpoIVFB inhibition mechanism could guide efforts to develop inhibitors of other IMMPs.